Olson, Brennan
Zhu, Xinxia
Norgard, Mason A.
Levasseur, Peter R.
Butler, John T.
Buenafe, Abigail
Burfeind, Kevin G.
Michaelis, Katherine A. http://orcid.org/0000-0002-3225-3649
Pelz, Katherine R.
Mendez, Heike
Edwards, Jared http://orcid.org/0000-0002-9108-3854
Krasnow, Stephanie M. http://orcid.org/0000-0003-0507-4669
Grossberg, Aaron J. http://orcid.org/0000-0003-4690-4948
Marks, Daniel L. http://orcid.org/0000-0003-2675-7047
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (F30CA254033, R01CA217989)
U.S. Department of Health & Human Services | National Institutes of Health (K08CA245188)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 15 May 2020
Accepted: 12 March 2021
First Online: 6 April 2021
Competing interests
: D.L.M. is a consultant for Pfizer, Inc. and Alkermes, Inc. D.L.M. is a consultant, has received grant funding, and has equity in Tensive Controls, Inc. The other authors declare no competing interests.